| Factor Information | |
|---|---|
| Data ID | 1767 |
| Factor | Men-Weight (Complex lesions 18–40 years) |
| Description | Male patients with complex lesions were shorter than controls whereas only men palliated with Fontan/TCPC and PA/DORV also had lower body weight and BMI. Further, among female patients, onlywomenwith ToF were shorter than controlswhereas no other differences were detected. |
| Biomarker | NA |
| Classification | E13 (physiological factor - weight) |
| Association | |
|---|---|
| Application | prognosis and risk assessment |
| Objective | BMI and the distribution in different BMI-classes in adults with CHD. |
| p Value | <0.001 |
| Conclusion | Male patients with complex lesions were shorter than controls whereas only men palliated with Fontan/TCPC and PA/DORV also had lower body weight and BMI. Further, among female patients, only women with TOF were shorter than controls whereas no other differences were detected. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 550 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | TCPC/TOF/PA/DORV/CoA/VSD/ASD/AS, AR |
| Reference | |
|---|---|
| PMID | 25838217 |
| Year | 2015 |
| Title | Height, weight and body mass index in adults with congenital heart disease |
| Sample | ||
|---|---|---|
| Population | Adults | |
| Source | Data extracted from the Swedish Registry on CHD | |
| Region | Stockholm, Sweden | |
| Method | N/A | |
| Race | European | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | PA/DORV(men)(Treatment) | control(men)(Control) |
| Number | 41 | 924 |
| Age | 27.0 ± 5.6 years | 28.3 ± 6.3 years |
| Gender (Male: Female) | 41:0 | 924:0 |
| Marker Level | 71.1 ± 13.4 kg | 81.6 ± 13.1 kg |
